IG-TATRA Study
Use of subcutaneous immunoglobulin (SCIG 20%) and hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) in Polish pediatric patients with primary immunodeficiency - a retrospective review.
RETROSPECTIVE STUDY
Dear Sir/Madam,
Dear Doctor,
We invite you to participate in a multicenter retrospective observational study entitled "Use of subcutaneous immunoglobulin (SCIG 20%) and hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) in Polish pediatric patients with primary immunodeficiency - a retrospective review", the main objective of which is to understand the administration patterns of immunoglobulins and determine the characteristics of Polish pediatric patients treated with SCIG 20% or fSCIG.
To start the study, it is necessary to sign an online agreement, so please register and follow the instructions on the computer screen.
After successful registration and electronic signing of the agreement, please log in using the credentials obtained during the account setup.
fSCIG (facilitated subcutaneous immunoglobulin) - subcutaneous immunoglobulin facilitated with hyaluronidase
SCIG (subcutaneous immunoglobulin) - subcutaneous immunoglobulin
